HB
Herborium Group, Inc.
HBRM · OTC
$0.00 +0.00% (+$0.00)
1M +9,900.00%
Market Cap $1.09M
P/E Ratio -
Div. Yield -
ROE 0.77%
Piotroski F-Score Weak
3/9Valuation
87 /100
Cheap EV/EBITDA 10.89x
P/S 0.98x
P/FCF 2.97x
Growth
40 /100
Stable Rev. growth 4.06%
EPS growth N/A
FCF growth N/A
Profitability
58 /100
Moderate Gross margin 55.77%
Net margin 2.64%
FCF margin 32.88%
Quality
30 /100
Poor ROIC 0.88%
ROE 0.77%
Asset turnover 7.16x
Debt
1 /100
High Current ratio 0.01x
Net debt/EBITDA 5.36x
Debt/Equity N/A
Stability
48 /100
Moderate Beta 7.24x
Rev. volatility 4.73%
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o HBRM
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Agnes Olszewski
Employees
2
Headquarters
Sugar Land